These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 21649492)

  • 1. Genetic information from archived blood spots.
    Resau J
    Bioanalysis; 2011 Jun; 3(11):1173-5. PubMed ID: 21649492
    [No Abstract]   [Full Text] [Related]  

  • 2. [Standardization and quality control in gene--based testing].
    Funato T; Takeda M
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():134-8. PubMed ID: 16416783
    [No Abstract]   [Full Text] [Related]  

  • 3. A three-step molecular protocol employing DNA obtained from dried blood spots for neonatal screening for 45,X Turner syndrome.
    Rocha MN; Melo MR; Longui CA; de Oliveira DV; Figueiredo CC; Pacchi PR
    Genet Mol Res; 2005 Dec; 4(4):749-54. PubMed ID: 16475121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction to molecular cystic fibrosis testing.
    Uphoff TS; Highsmith WE
    Clin Lab Sci; 2006; 19(1):24-31. PubMed ID: 16617555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening by DNA analysis of dried blood spots.
    Rubin EM; Andrews KA; Kan YW
    Hum Genet; 1989 May; 82(2):134-6. PubMed ID: 2722189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Operational issues for implementation of donor genotyping for red blood cell antigens.
    Nance ST
    Transfusion; 2007 Jul; 47(1 Suppl):69S-72S. PubMed ID: 17593290
    [No Abstract]   [Full Text] [Related]  

  • 7. [Screening for fragile X syndrome. International experiences].
    Vuust J; Larsen LA; Grønskov K; Nørgaard-Pedersen B; Brøndum-Nielsen K
    Ugeskr Laeger; 2006 Oct; 168(43):3704-9. PubMed ID: 17069733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory diagnosis of alpha1-antitrypsin deficiency.
    Ferrarotti I; Scabini R; Campo I; Ottaviani S; Zorzetto M; Gorrini M; Luisetti M
    Transl Res; 2007 Nov; 150(5):267-74. PubMed ID: 17964515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening and genetic testing.
    Kenner C; Moran M
    J Midwifery Womens Health; 2005; 50(3):219-26. PubMed ID: 15895000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic testing and gene-based testing for endocrine disorders].
    Yanase T; Nawata H
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():207-11. PubMed ID: 16416795
    [No Abstract]   [Full Text] [Related]  

  • 11. Minority HIV mutation detection in dried blood spots indicates high specimen integrity and reveals hidden archived drug resistance.
    Wei X; Youngpairoj AS; Garrido C; Zahonero N; Corral A; de Mendoza C; Heneine W; Johnson JA; Garcia-Lerma JG
    J Clin Virol; 2011 Feb; 50(2):148-52. PubMed ID: 21130027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA STAT: the ability to perform clinical analysis in real time.
    Tsongalis GJ
    Expert Rev Mol Diagn; 2005 Sep; 5(5):627-8. PubMed ID: 16149864
    [No Abstract]   [Full Text] [Related]  

  • 13. [From sample collection to testing. F. Blood specimen collection from newborn infants].
    Nishida H
    Rinsho Byori; 1996 Nov; Suppl 103():44-7. PubMed ID: 9190422
    [No Abstract]   [Full Text] [Related]  

  • 14. Hereditary retinal disease.
    Goodwin P
    Curr Opin Ophthalmol; 2008 May; 19(3):255-62. PubMed ID: 18408503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semi-quantitative method for determination of hematocrit in dried blood spots, using data collected in HPLC hemoglobin variant testing.
    Orsini JJ; Yeman J; Caggana M; Bodamer OA; Mühl A
    Clin Chim Acta; 2010 Jun; 411(11-12):894-5. PubMed ID: 20230811
    [No Abstract]   [Full Text] [Related]  

  • 16. [Forensic medicine and genetic testing].
    Nata M
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():395-9. PubMed ID: 16416824
    [No Abstract]   [Full Text] [Related]  

  • 17. Establishment of stably EBV-transformed cell lines from residual clinical blood samples for use in performance evaluation and quality assurance in molecular genetic testing.
    Bernacki SH; Stankovic AK; Williams LO; Beck JC; Herndon JE; Snow-Bailey K; Prior TW; Matteson KJ; Wasserman LM; Cole EC; Stenzel TT
    J Mol Diagn; 2003 Nov; 5(4):227-30. PubMed ID: 14573781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic testing for inherited disorders.
    Pagon RA
    Expert Rev Mol Diagn; 2004 Mar; 4(2):135-40. PubMed ID: 14995901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic risk prediction--are we there yet?
    Kraft P; Hunter DJ
    N Engl J Med; 2009 Apr; 360(17):1701-3. PubMed ID: 19369656
    [No Abstract]   [Full Text] [Related]  

  • 20. Liberty, privacy, and DNA databases.
    Rosen C
    New Atlantis; 2003; (1):37-52. PubMed ID: 15584193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.